Evolving thresholds for liver transplantation in hepatocellular carcinoma: A Western experience

被引:14
作者
Ju, Michelle R. [1 ]
Yopp, Adam C. [1 ]
机构
[1] Univ Texas Southwestern Med Ctr Dallas, Dept Surg, Div Surg Oncol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA
关键词
hepatocellular carcinoma; liver transplant selection; organ stewardship; transplant criteria; transplantation; RECURRENCE; CANCER; MANAGEMENT; EXPANSION; RESECTION; CRITERIA; MODEL;
D O I
10.1002/ags3.12316
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Hepatocellular carcinoma (HCC) is the second leading cause of cancer-related deaths worldwide. Once considered an experimental treatment with dismal survival rates, liver transplantation for HCC entered a new era with the establishment of the Milan criteria over 20 years ago. In the modern post-Milan-criteria era, 5-year survival outcomes are now upwards of 70% in select patients. Liver transplantation (LT) is now considered the optimal treatment for patients with moderate to severe cirrhosis and HCC, and the rates of transplantation in the United States are continuing to rise. Several expanded selection criteria have been proposed for determining which patients with HCC should be candidates for undergoing LT with similar overall and recurrence-free survival rates to patients within the Milan criteria. There is also a growing experience with downstaging of patients who fall outside conventional LT criteria at the time of HCC diagnosis with the goal of tumor shrinkage via locoregional therapies to become a candidate for transplantation. The aim of this review article is to characterize the various patient selection criteria for LT, discuss balancing organ stewardship with outcome measures in HCC patients, present evidence on the role of downstaging for large tumors, and explore future directions of LT for HCC.
引用
收藏
页码:208 / 215
页数:8
相关论文
共 46 条
[11]   Managements of recurrent hepatocellular carcinoma after liver transplantation: A systematic review [J].
de'Angelis, Nicola ;
Landi, Filippo ;
Carra, Maria Clotilde ;
Azoulay, Daniel .
WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (39) :11185-11198
[12]   Liver Transplantation for Advanced Hepatocellular Carcinoma Using Poor Tumor Differentiation on Biopsy as an Exclusion Criterion [J].
DuBay, Derek ;
Sandroussi, Charbel ;
Sandhu, Lakhbir ;
Cleary, Sean ;
Guba, Markus ;
Cattral, Mark S. ;
McGilvray, Ian ;
Ghanekar, Anand ;
Selzner, Markus ;
Greig, Paul D. ;
Grant, David R. .
ANNALS OF SURGERY, 2011, 253 (01) :166-172
[13]   Recurrence-free survival more than 10 years after liver resection for hepatocellular carcinoma [J].
Eguchi, S. ;
Kanematsu, T. ;
Arii, S. ;
Omata, M. ;
Kudo, M. ;
Sakamoto, M. ;
Takayasu, K. ;
Makuuchi, M. ;
Matsuyama, Y. ;
Monden, M. .
BRITISH JOURNAL OF SURGERY, 2011, 98 (04) :552-557
[14]   Hepatocellular carcinoma: Epidemiology and molecular carcinogenesis [J].
El-Serag, Hashem B. ;
Rudolph, Lenhard .
GASTROENTEROLOGY, 2007, 132 (07) :2557-2576
[15]  
FALKSON G, 1988, CANCER RES, V48, P7314
[16]   Hepatectomy for hepatocellular carcinoma: Toward zero hospital deaths [J].
Fan, ST ;
Lo, CM ;
Liu, CL ;
Lam, CM ;
Yuen, WK ;
Yeung, C ;
Wong, J .
ANNALS OF SURGERY, 1999, 229 (03) :322-330
[17]   Hepatocellular carcinoma recurrence after liver transplantation: Risk factors, screening and clinical presentation [J].
Filgueira, Norma Arteiro .
WORLD JOURNAL OF HEPATOLOGY, 2019, 11 (03) :261-272
[18]   An analysis of 412 cases of hepatocellular carcinoma at a western center [J].
Fong, YM ;
Sun, RL ;
Jarnagin, W ;
Blumgart, LH .
ANNALS OF SURGERY, 1999, 229 (06) :790-799
[19]   Hepatocellular carcinoma [J].
Forner, Alejandro ;
Llovet, Josep M. ;
Bruix, Jordi .
LANCET, 2012, 379 (9822) :1245-1255
[20]   Adult living donor liver transplantation for patients with hepatocellular carcinoma -: Extending UNOS priority criteria [J].
Gondolesi, GE ;
Roayaie, S ;
Muñoz, L ;
Kim-Schluger, L ;
Schiano, T ;
Fishbein, TM ;
Emre, S ;
Miller, CM ;
Schwartz, ME .
ANNALS OF SURGERY, 2004, 239 (02) :142-149